By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Health and Life Sciences stand at the cutting edge of technological and research advancements, presenting unique opportunities for transformative progress and enduring value, supporting healthy aging and extending healthspan.
The Goal

Accelerating Breakthrough Innovation

Our commitment to advancing health and life sciences is reflected in our two specialised investment funds.

The 3xP Global Health Innovation Fund, combining private equity and venture capital, invests in capacity building to drive innovation efficiently across the value chain, from discovery to development and production.

Meanwhile, the 3xP Global SIF Innovation Fund is dedicated to supporting breakthroughs in medical care, with a focus on cutting-edge therapies and innovations shaping the future of healthcare.

sector-specific Funds

Our Commitment to Health and Life Sciences

The SIF Innovation Fund invests in cutting-edge companies excelling in technology, mainly in health and life sciences. Guided by the UN Principles for Responsible Investment (UN PRI), we focus on sectors like Biotechnology, Artificial Intelligence, Blockchain, and Nanotechnology.

Our main goal is to support innovations that drive positive change and contribute to the UN Sustainable Development Goals (UN SDGs), regarding Goold Health and Well Being. Committed to integrating R&D with robust ESG practices, we promote a circular economy while delivering long-term value and resilience.

0
M €
Fund Size
0
Inception Year
0
Maturity

Our Health Innovation Fund is focused on shaping the future of healthcare by leveraging opportunities within Portugal’s thriving CDMO market, a cornerstone of the biopharma industry driven by increasing demand for specialised capabilities in biologics and advanced therapies.

We are targeting high-growth opportunities in healthcare and biotech, fostering synergies across our portfolio to drive innovation in digital health, AI-driven drug discovery, and early-stage healthspan-focused therapeutics.

0
M €
Fund Size
0
Inception Year
0
Maturity

O Health Innovation, Fundo de Capital de Risco Fechado é co-financiado em 60% pelo Fundo de Capitalização e Resiliência (FdCR), gerido pelo Banco Português de Fomento, no âmbito do Programa Consolidar.


Saiba mais em bpfomento.pt/pt/prr/ e recuperarportugal.gov.pt.

Our portfolio

LoopOS

The all-in-one ERP for the circular economy that centralises buybacks, returns, trade-ins, repairs, C2C and rentals - while measuring the impact of these channels. LoopOS is a Green Innovation SaaS ERP that makes everything easy through drag-and-drop flows and a customisable interface. LoopOS transforms the way companies integrate the world of circularity into their business model, with a commitment to people and the planet.

Qevo

With the goal of implementing a new concept that will forever change the way people think about and use queue management software, Qevo is focused on democratising queue systems and the overall user experience. Already with a proven cloud product and some major customers in hand, the company is now expanding its operations and continuing to evolve our product with new paradigms and features for the global public.

Headquarters
Lisbon
Investment Year
2024
Status

Leadzai

Leadzai is a customer acquisition platform that enables businesses to grow online. Driven by the belief that the digital advertising market is failing to help businesses get a satisfactory return on their advertising investment, Leadzai's mission is to enable the next 200 million businesses to grow effortlessly.

Headquarters
Lisbon
Investment Year
2024
Status

Exogenus Therapeutics

Innovative biotech start-up dedicated to the early development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases.

Headquarters
Cantanhede
Investment Year
2024
Status

Skill Augment

Through Augmented Reality (AR) technologies, Skill Augment helps industrial companies reduce errors, leading to more efficient resource allocation and a positive environmental impact. The company has already partnered with some of the world’s most prestigious car manufacturers, further showcasing its impact on the industry.

Headquarters
Lisbon
Investment Year
2023
Status

Kinetikos Health

Kinetikos Health supports the monitoring and management of motor skills by analysing data from smartphones without the need for other devices. Applications range from the monitoring of diseases such as Parkinson's, to movement disorders associated with other pathologies, to the monitoring of elite athletes. The solution is already recognised as a Class 1 medical device in Europe and has received CE Mark certification in 2020.

Headquarters
Coimbra
Investment Year
2023
Status

Biometrid

Focusing on remote ID recognition and authentication, Biometrid, SA has developed a digital platform based on documentation validation systems, multimodal biometric technology, life, emotions and behavior detection systems, among others. This solution has different use cases, from remote contracting to validating transactions with strong authentication.

Headquarters
Porto
Investment Year
2023
Status

Sioslife

Aligned with the social responsible principles inherent to 3xP Global and the managed funds, Sioslife contributes directly to the senior people well being. The company focuses on the development of i) solutions to simulate brain and physical activity on elderly people, and ii) software that allows social institutions to provide more systematic and effective care support, both in senior residences and remotely.

Headquarters
Braga
Investment Year
2021
Status

LiMM

Being currently dormant, LiMM biotech activity focused on the development of therapeutic products for the treatment of inflammatory, infectious, and metabolic diseases. The project was born inside Champalimaud, a prominent European health foundation on the cancer treatment research.

Headquarters
Investment Year
2021
Status
Website

Sea4us

Having their roots in the deep blue ocean, Sea4us is a biotech that has been studying the maritime flora, searching for new and powerful therapeutic principles.

Sea4Us is a biotech focused on research and development of novel pharma products based on marine components for unmet clinical needs, now developing an analgesic product. Sea4Us has an extensive and exclusive library on marine components.

Headquarters
Sagres
Investment Year
2021
Status

PeekMed

Being the first company invested by the Sustainable Innovation Fund, Peekmed is at the forefront of innovation. The company has been developing solutions for the IA planning of orthopedic procedures, having, on their clients list, most of the global top orthopedic manufacturers and players

Headquarters
Braga
Investment Year
2021
Status

Instituto Galénico

IG provides contract manufacturing for medical devices, cosmetics, and supplements, with a focus on water-based formulations. Its advanced production capabilities support aging-focused innovations, from dermatological longevity products to next-generation supplements. IG’s rapid growth reflects its expanding portfolio and rising demand for wellness-focused products, driven by strong-performing heritage products like saline solutions and disinfectants.

Headquarters
Santarém
Investment Year
2024
Status

Mútua Saúde

MPS is a next-generation health insurer offering inclusive coverage without age restrictions or exclusions for pre-existing conditions. By removing traditional barriers to care, MPS enhances access to preventative healthcare and early interventions, key to extending healthspan. Its growth is fueled by a scalable model that prioritizes accessibility and innovation in health insurance, positioning MPS as a key player in the sector.

Headquarters
Lisbon
Investment Year
2024
Status
Our Differentiation

Why Partner with Us

Let's Talk

Portugal’s Prime Position for Healthcare Innovation

Capitalize on Portugal’s thriving Contract Development and Manufacturing Organisation (CMDO) sector, offering high-quality pharmaceutical services at competitive costs.

Diversified Investment Strategy Driving Healthspan

Take advantage of a comprehensive investment strategy that balances risk and maximises growth opportunities across healthtech and biotech, with a focus on promoting healthy aging.

30+ Years of Proven Expertise in Managing ESG Strategies

Efficiently allocate grant resources to ensure higher financial returns and impactful outcomes from your investments.

Founders Stories

Lorem Ipsum has Been The Industry's

Lorem Ipsum
Lorem Ipsum has been
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Frequently Asked Questions

Let’s Answer
Your Questions

Some random question that we have to add here 7

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here 6

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here 5

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here 4

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here 3

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here 2

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Some random question that we have to add here

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry's standard dummy text ever since the 1500s.

Contact us

Get in Touch

Send Message
Thank you for contacting us.
We will get back to you shortly.
Oops! Something went wrong while submitting the form. Please try again or contact us.
Our Other Verticals

Explore our Other Fields of Expertise

Our Strategy

Tailor Made Solutions

Crafting custom strategies that unlock success across diverse industries.

Impact Investing

Building long-term positive systemic solutions with tangible societal impact.